Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry (Q51735658)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 30, 2010

edit

Language	Label	Description	Also known as
English	Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry	scientific article published on December 30, 2010

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

title

Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry (English)

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

author

Gilbert Habib

series ordinal

3

object named as

Gilbert Habib

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

Sylvestre Maréchaux

series ordinal

5

object named as

Sylvestre Maréchaux

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

Christophe Tribouilloy

series ordinal

2

object named as

Christophe Tribouilloy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

Florent Le Ven

series ordinal

1

object named as

Florent Le Ven

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

author name string

Jean-Pierre Gueffet

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

Jean-Christophe Eicher

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

Bénédicte Blanchard-Lemoine

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

Juliette Rousseau

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

Pierre Hénon

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

Yannick Jobic

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

Yves Etienne

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

21193484

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21193484

retrieved

21 November 2024

publication date

30 December 2010

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

full work available at URL

https://academic.oup.com/ehjcimaging/article-pdf/12/4/265/7136848/jeq172.pdf

file format

PDF

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21193484

retrieved

21 November 2024

http://academic.oup.com/ehjcimaging/article-pdf/12/4/265/7136848/jeq172.pdf

file format

PDF

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

published in

European Journal of Echocardiography

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

volume

12

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

page(s)

265-271

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

cites work

Efficacy of benfluorex in combination with sulfonylurea in type 2 diabetic patients: an 18-week, randomized, double-blind study

1 reference

stated in

COCI

retrieved

5 June 2022

reference URL

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIACARE.29.03.06.DC05-1439

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

series ordinal

1

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine/fenfluramine

series ordinal

2

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Valvular heart disease associated with fenfluramine-phentermine

series ordinal

3

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals

series ordinal

4

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Valvular heart disease in a patient taking benfluorex

series ordinal

6

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Fenfluramine-like cardiovascular side-effects of benfluorex.

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Valvular heart disease associated with benfluorex

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Restrictive organic mitral regurgitation associated with benfluorex therapy

series ordinal

10

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Benfluorex and unexplained valvular heart disease: a case-control study

series ordinal

11

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease).

series ordinal

12

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)

series ordinal

13

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice

series ordinal

14

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Drug-induced fibrotic valvular heart disease

series ordinal

15

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Drugs and valvular heart disease

series ordinal

16

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Chronic fenfluramine administration increases plasma serotonin (5-hydroxytryptamine) to nontoxic levels.

series ordinal

17

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin.

series ordinal

18

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

An investigation of the serotonergic effects of fenfluramine, dexfenfluramine and dexnorfenfluramine using platelets as neuronal models

series ordinal

19

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Role of echocardiography in toxic heart valvulopathy

series ordinal

20

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications

series ordinal

21

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group

series ordinal

22

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months

series ordinal

23

1 reference

stated in

Crossref

DOI

10.1093/EJECHOCARD/JEQ172

reference URL

https://api.crossref.org/works/10.1093/EJECHOCARD/JEQ172

retrieved

21 November 2024

Identifiers

DOI

10.1093/EJECHOCARD/JEQ172

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

PubMed publication ID

21193484

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21193484

retrieved

11 April 2018

reference URL

http://europepmc.org/abstract/MED/21193484

ResearchGate publication ID

49716663

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51735658&oldid=2277728829"